Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.
Nature. 2025;646(8084):462-473 - PMID: 40836096 - PMCID: PMC12406299 - DOI: 10.1038/s41586-025-09370-8
Novel approaches to clinical trial design in cancer neuroscience.
Neuron. 2025;113(17):2791-2813 - PMID: 40907474 - PMCID: PMC12435926 - DOI: 10.1016/j.neuron.2025.08.015
Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer.
InSituCor: exploring spatially correlated genes conditional on the cell type landscape.
Integrative genomic identification of therapeutic targets for pancreatic cancer.
Cell Rep. 2025;44(9):116191 - PMID: 40848256 - DOI: 10.1016/j.celrep.2025.116191
The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancer.
Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors.
Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer.
8
CSV